Workflow
Coco Healthcare(301009)
icon
Search documents
可靠股份(301009) - 2021年9月6日投资者关系活动记录表
2022-11-21 16:10
证券代码:301009 证券简称:可靠股份 杭州可靠护理用品股份有限公司投资者关系活动记录表 编号:2021-006 | --- | --- | --- | |-------------------------|----------------------------------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ...
可靠股份(301009) - 2021年7月5日投资者关系活动记录表
2022-11-21 16:10
证券代码:301009 证券简称:可靠股份 杭州可靠护理用品股份有限公司投资者关系活动记录表 编号:2021-003 | --- | --- | --- | |-------------------------|----------------------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------| | | | | | 投资者关系活 | √ 特定对象调研 | □ 分析师会议 | | 动类别 | □ 媒体采访 ...
可靠股份(301009) - 2021年9月10日投资者关系活动记录表
2022-11-21 16:10
证券代码:301009 证券简称:可靠股份 杭州可靠护理用品股份有限公司投资者关系活动记录表 编号:2021-007 | --- | --- | --- | |-------------------------|---------------------------------------------------------------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ ...
可靠股份(301009) - 2022年5月10日 投资者关系活动记录
2022-11-19 03:38
编号:2022-002 证券代码:301009 证券简称:可靠股份 杭州可靠护理用品股份有限公司投资者关系活动记录表 | --- | --- | --- | |-------------------------|--------------------------------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ...
可靠股份(301009) - 2022年10月12日投资者关系活动记录表
2022-11-11 02:16
编号:2022-004 证券代码:301009 证券简称:可靠股份 杭州可靠护理用品股份有限公司投资者关系活动记录表 | --- | --- | --- | |--------------|----------------------------------|-----------------------------------------------------------------------------------------------------------| | 投资者关系活 | √ 特定对象调研 | □ 分析师会议 | | 动类别 | □ 媒体采访 | □ 业绩说明会 | | | □ 新闻发布会 | □ 路演活动 | | | □ 现场参观 | | | | □ 其他 | ( ) | | 参与单位名称 | 东亚前海证券 林鑫 | | | 及人员姓名 | 菲洛资产 张文丽 | | | | 黑皇资产 陈俊龙 | | | | 东巍资产 王毅 | | | 时间 | 2022年10月12 日 | | | 地点 | 浙江省杭州市临安区锦城街道花桥路 | 2 号 | | 上市公司参与 | | 董事长金利伟、财务 ...
可靠股份(301009) - 2022年8月27日投资者关系活动记录表
2022-11-11 00:22
证券代码:301009 证券简称:可靠股份 杭州可靠护理用品股份有限公司投资者关系活动记录表 编号:2022-003 | --- | --- | --- | |-------------------------|----------------------------------|--------------------------------------------------------------------| | | | | | 投资者关系活 | □ 特定对象调研 | □ 分析师会议 | | 动类别 | □ 媒体采访 | □ 业绩说明会 | | | □ 新闻发布会 | □ 路演活动 | | | □ 现场参观 | | | | 其他 | ( 投资者电话会议 ) | | 参与单位名称 及人员姓名 | 详见附件 | | | 时间 | 2022年8 月27日 | | | 地点 | 浙江省杭州市临安区锦城街道花桥路 | 2 号 | | 上市公司参与 | | 董事长兼总经理金利伟、财务总监徐鸣、证券事务代表徐思敏 | | 人员姓名 | 一、公司经营管理层介绍公司 | 2022 年半年度基本情况 | | | 公司继续 ...
可靠股份(301009) - 2022年10月27日投资者关系活动记录表
2022-10-30 13:18
证券代码:301009 证券简称:可靠股份 杭州可靠护理用品股份有限公司投资者关系活动记录表 编号:2022-005 | --- | --- | --- | |-----------------------|---------------------------------------|--------------------------------------------------------------------------------------------------------------| | | | | | 投资者关系活 | | 特定对象调研 □分析师会议 | | 动类别 | | □媒体采访 □业绩说明会 | | | □新闻发布会 □路演活动 | | | | □现场参观 | | | | 其他 | ( 投资者电话会议 ) | | 参与单位名称 | 详见附件 | | | 及人员姓名 | | | | 时间 | 2022年10月27 日 | | | 地点 | 浙江省杭州市临安区锦城街道花桥路 | 2 号 | | 上市公司参与 人员姓名 | | 董事长兼总经理金利伟、财务总监徐鸣、证券事务代表徐思敏 ...
可靠股份(301009) - 2022 Q3 - 季度财报
2022-10-26 16:00
杭州可靠护理用品股份有限公司 2022 年第三季度报告 1 2022 年第三季度报告 □是 否 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚假记载、误 导性陈述或重大遗漏。 重要内容提示: 2.公司负责人、主管会计工作负责人及会计机构负责人(会计主管人员)声明:保证季度报 告中财务信息的真实、准确、完整。 3.第三季度报告是否经过审计 证券代码:301009 证券简称:可靠股份 公告编号:2022-053 杭州可靠护理用品股份有限公司 1.董事会、监事会及董事、监事、高级管理人员保证季度报告的真实、准确、完整,不存 在虚假记载、误导性陈述或重大遗漏,并承担个别和连带的法律责任。 杭州可靠护理用品股份有限公司 2022 年第三季度报告 一、主要财务数据 (一) 主要会计数据和财务指标 公司是否需追溯调整或重述以前年度会计数据 □是 否 | | 本报告期 | 本报告期比上年同 | 年初至报告期末 | 年初至报告期末比 | | --- | --- | --- | --- | --- | | | | 期增减 | | 上年同期增减 | | 营业收入(元) | 272,994,762.56 | 15. ...
可靠股份(301009) - 2022 Q2 - 季度财报
2022-08-26 16:00
Financial Performance - The company's operating revenue for the first half of 2022 was approximately ¥576.13 million, a decrease of 8.59% compared to ¥630.29 million in the same period last year[26]. - The net profit attributable to shareholders of the listed company was ¥554,914.39, down 99.18% from ¥67.36 million in the previous year[26]. - The net profit after deducting non-recurring gains and losses was a loss of ¥2.82 million, compared to a profit of ¥64.60 million in the same period last year, representing a decline of 104.36%[26]. - The cash flow from operating activities showed a net outflow of ¥3.44 million, a decrease of 119.03% compared to a positive cash flow of ¥18.10 million in the previous year[26]. - Basic and diluted earnings per share were both ¥0.0020, down 99.39% from ¥0.33 in the same period last year[26]. - The weighted average return on net assets was 0.04%, a decrease of 10.37% from 10.41% in the previous year[26]. - The company reported a revenue of ¥576,126,971.60 for the current period, a decrease of 8.59% compared to ¥630,287,491.94 in the previous year, primarily due to a decline in birth rates affecting baby product sales[58]. - The company's operating costs increased by 5.69% to ¥505,938,027.07, attributed to rising material costs and logistics expenses[58]. - Sales expenses rose significantly by 33.53% to ¥49,775,326.86, driven by increased brand promotion and channel expansion efforts[58]. - Management expenses increased by 36.20% to ¥15,450,451.43, mainly due to salary adjustments and increased land costs[58]. Assets and Liabilities - Total assets at the end of the reporting period were approximately ¥2.09 billion, a slight increase of 0.03% from ¥2.08 billion at the end of the previous year[26]. - The net assets attributable to shareholders of the listed company were approximately ¥1.40 billion, down 1.31% from ¥1.41 billion at the end of the previous year[26]. - The total cash and cash equivalents decreased by 111.67% to -¥87,077,437.41, mainly due to increased fixed asset investments and dividend distributions from 2021[62]. - The accounts receivable increased to ¥246,560,421.67, representing 11.82% of total assets, up 3.36% year-on-year[66]. - Total liabilities rose to CNY 599,176,346.65 from CNY 578,586,887.87, marking an increase of about 3.4%[162]. - The company's equity attributable to shareholders decreased to CNY 1,396,245,353.40 from CNY 1,414,729,191.37, a decline of approximately 1.3%[162]. Market Position and Products - The company has a leading position in the adult incontinence products market, with a market share of 9.8% in 2021, while the overall market for absorbent hygiene products decreased by 5.9%[44]. - The compound annual growth rate for adult incontinence products consumption from 2018 to 2021 reached 18%, contrasting with a decline of 3.9% for baby diapers[45]. - The company operates under a dual-driven model of "own brand + ODM," focusing on adult incontinence, baby care, and pet hygiene products[34]. - The company has developed high-end products specifically designed for Asian women and men, including invisible absorbent pads and ultra-thin breathable adult diapers[35]. - The company has established deep partnerships with well-known baby care brands, leveraging over 20 years of industry experience[34]. - The company has upgraded its "Absorbent Treasure" product line in terms of packaging and performance starting in 2022[36]. Research and Development - The company holds a total of 271 patents, including 51 invention patents, with 22 new patents acquired in 2022, indicating strong R&D capabilities[47]. - Research and development expenses increased by 6.20% to ¥25,097,988.20, reflecting a rise in R&D investment during the reporting period[62]. - The company has implemented a strategy to manage the release of restricted shares, with specific dates for unlocking shares for various stakeholders[140]. Risks and Challenges - The company faces risks from currency fluctuations, particularly as transactions with overseas clients are typically priced and settled in USD, which may impact operational performance due to exchange rate volatility[88]. - The declining birth rate in China poses a risk to the baby hygiene products market; the company plans to expand its market share in adult incontinence products to mitigate this impact[90]. - Increased competition in the disposable hygiene products industry, especially for baby products, necessitates ongoing investment in product development and brand building to maintain market share[92]. - The company has a high customer concentration risk, primarily relying on major clients like JS in the Philippines, and aims to diversify its customer base to reduce dependency[91]. Corporate Governance and Social Responsibility - The company emphasizes the importance of risk awareness regarding forward-looking statements and potential risks in its operations[4]. - The company actively engages in social responsibility initiatives, including providing care consultations and product samples for elderly individuals during a sports event[105]. - The company celebrated the fifth anniversary of "Hope Home" in Lin'an, contributing physical donations and participating in charitable activities[106]. - The company has implemented a shareholder return program to thank investors for their support since its IPO, resulting in positive interactions[106]. Future Outlook - The company plans to expand its market presence by launching new products in the second half of 2022[192]. - The management provided a revenue guidance of 1.2 billion yuan for the full year 2022, expecting a growth rate of 5%[192]. - The company is exploring potential mergers and acquisitions to strengthen its market position and diversify its product offerings[192]. - The company aims to enhance its production capacity by 15% through strategic investments in new facilities[192].
可靠股份(301009) - 2021 Q4 - 年度财报
2022-04-22 16:00
Financial Performance - The company reported a profit distribution plan, proposing a cash dividend of 0.70 RMB per 10 shares based on a total of 271,860,000 shares[5]. - The company's operating revenue for 2021 was ¥1,186,403,782.94, a decrease of 27.44% compared to ¥1,635,131,559.07 in 2020[20]. - The net profit attributable to shareholders was ¥39,745,305.90, down 81.43% from ¥214,010,338.13 in the previous year[20]. - The net cash flow from operating activities was ¥50,525,107.06, reflecting a decline of 87.24% compared to ¥395,857,840.02 in 2020[20]. - The total assets at the end of 2021 increased by 39.60% to ¥2,085,632,908.86 from ¥1,493,966,929.22 at the end of 2020[20]. - The net assets attributable to shareholders rose by 130.63% to ¥1,414,729,191.37 from ¥613,425,459.94 in 2020[20]. - The basic earnings per share decreased by 83.81% to ¥0.17 from ¥1.05 in 2020[20]. - The weighted average return on equity dropped to 3.92% from 42.28% in the previous year, a decline of 38.36%[20]. - The company achieved a total revenue of ¥1,186,403,782.94 in 2021, representing a decrease of 27.44% compared to the previous year[65]. - The revenue from the company's own brand business was ¥391,042,204.20, accounting for 32.96% of total revenue, which is a decline of 12.05% year-on-year[69]. - The ODM business generated revenue of ¥777,881,239.90, making up 65.57% of total revenue, with a year-on-year decrease of 33.81%[69]. - The company reported a significant increase in revenue, achieving a total of 1.2 billion CNY in 2021, representing a year-over-year growth of 15%[123]. - The company reported a significant increase in revenue, achieving a total of 1.5 billion yuan for the fiscal year, representing a 20% year-over-year growth[194]. Market Position and Competition - The company confirmed that its main business and core competitiveness have not experienced significant adverse changes, aligning with industry trends[5]. - The company faces risks from increasing market competition and significant fluctuations in raw material prices, as detailed in the management discussion section[5]. - The disposable personal hygiene products market in China reached a scale of 121.4 billion RMB in 2020, growing by 4.2% compared to 2019[30]. - The adult incontinence products market size was 11.5 billion RMB in 2020, representing a growth of 22.5% from 2019[30]. - The company ranked first in the domestic adult incontinence products market according to the Life Paper Committee's annual report for 2021[35]. - The competitive landscape in the adult incontinence products market is intensifying, necessitating continuous product and channel innovation to maintain industry leadership[119]. - High customer concentration risk exists, with major clients being key strategic partners; the company aims to expand its customer base globally to mitigate this risk[120]. Product Development and Innovation - The company has established a strong brand image and is recognized as one of the top ten enterprises in the adult incontinence products industry in China[34]. - The company has a diverse product line including adult diapers, adult pull-ups, and nursing pads, catering to various market segments[36]. - The company is committed to product innovation and has a dedicated R&D team to enhance its product offerings[34]. - The company launched new products targeting the light incontinence market, including specially designed products for Asian women, expanding its product range[61]. - The company is developing several new products, including ultra-thin comfortable baby diapers and medical-grade baby diapers, aiming to enhance product competitiveness and market presence[83]. - New product development efforts are focused on eco-friendly nursing products, with an investment of 50 million CNY allocated for R&D in 2022[123]. - The company is investing 100 million CNY in R&D for new technologies aimed at enhancing product efficiency and user experience[193]. - The company plans to increase R&D investment in 2022, aiming to enrich its product line and meet consumer demands through innovation and collaboration with academic institutions[112]. Strategic Initiatives and Partnerships - The company operates under a dual-driven model of "own brand + ODM," focusing on both self-owned brands and high-end manufacturing[36]. - The company has formed strategic partnerships with top research institutions to enhance R&D capabilities and accelerate product development[48]. - The company has established a direct sales model with key accounts, including major retailers like RT-Mart and Walmart, enhancing market reach[44]. - The online sales strategy includes e-commerce platforms such as Tmall, JD.com, and Pinduoduo, along with emerging channels like live streaming and community group buying[45]. - The company is considering strategic acquisitions to enhance its product portfolio, with a budget of 300 million CNY allocated for potential mergers and acquisitions[194]. Financial Management and Governance - The company’s financial report has been confirmed as true, accurate, and complete by its management team[4]. - The company has established an independent financial accounting department with a compliant accounting system and financial management practices[136]. - The company has a complete and independent business system, capable of operating independently in the market without reliance on shareholders or related parties[139]. - The company has a clear separation of production and office locations from controlling shareholders, ensuring operational independence[138]. - The company has established a robust internal control system, ensuring compliance and effective implementation to protect shareholder rights[177]. - The company has maintained compliance with regulations set by the China Securities Regulatory Commission and the Shenzhen Stock Exchange[163]. - The company has a structured remuneration system for core technical personnel based on labor contracts and company policies[154]. - The company has committed to enhancing fundraising management to ensure proper and legal use of raised funds[198]. Risk Management - The company emphasizes the importance of risk awareness regarding forward-looking statements related to future plans and development strategies[5]. - The company faces foreign exchange risk due to pricing in USD, which may impact operating performance amid significant fluctuations in the RMB/USD exchange rate[116]. - Raw material price volatility poses a risk, but the company maintains strong bargaining power with suppliers to stabilize procurement costs[117]. - The company is exposed to macroeconomic risks, with consumer demand linked to disposable income and inflation, prompting a strategy to diversify product offerings[118]. Social Responsibility and Sustainability - The company actively engages in social responsibility initiatives, focusing on employee rights and community involvement[183]. - The company is committed to environmental protection by developing biodegradable materials for its products, contributing to pollution reduction[187]. - The company has engaged in poverty alleviation and rural revitalization efforts, including donations for local infrastructure projects[188]. - The company has a commitment to sustainability, with plans to reduce production waste by 25% over the next two years[193]. Future Outlook - The company provided a positive outlook for 2022, projecting a revenue growth of 10% to 15% based on market expansion strategies and new product launches[123]. - The company aims to expand its market presence in Southeast Asia, targeting a 25% increase in market share within the region over the next two years[123]. - The company plans to enhance its online sales channels, aiming for a 30% increase in e-commerce revenue by the end of 2022[193]. - The company aims to maintain independence in its operations and avoid any actions that could affect its independence from related parties[195].